Key result
Quinidine, metoprolol, and an ICD prevent ventricular arrhythmias over 12 months in a KCND3 channelopathy case.
Why the study?
Early repolarization syndrome is rare in children, and KCND3 mutations causing mixed cardiac and cerebral channelopathy phenotypes are rarely reported.
Case Report (n=1)
No
Highlights the rare presentation of cardiocerebral channelopathy due to KCND3 mutation and its successful management with quinidine, metoprolol, and an ICD.
Answers are grounded in this paper and cite their sources.
Cautious support for this regimen in KCND3 channelopathy; hypothesis-generating and requires larger studies before adoption.
Early repolarization syndrome is rare in children. Mutation of genes encoding ion channels could display mixed electrophysiological phenotype of Kv4.3 including both cardiac phenotype (early repolarization syndrome, atrial fibrillation) and cerebral phenotype (epilepsy, intellectual disability). This situation is rare and was named as cardiocerebral channelopathy. Here, we report a case of an 11-year-old-girl with cardiocerebral channelopathy caused by KCND3 mutation, who was successfully treated with oral quinidine, metoprolol and implantable cardioverter-defibrillator. Clinicians should be vigilant on the risk of cardiogenic syncope and sudden cardiac death in a patient with epilepsy, intellectual disability and early repolarization pattern.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) conducted a case report in Cardiocerebral channelopathy (KCND3 mutation) (n=1). Quinidine, metoprolol, and implantable cardioverter-defibrillator (ICD) was evaluated on Recurrence of ventricular arrhythmias or ICD shocks. In an 11-year-old girl with cardiocerebral channelopathy caused by a KCND3 mutation, treatment with oral quinidine, metoprolol, and an ICD successfully prevented ventricular arrhythmias and ICD shocks over 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: